![JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in](https://www.mdpi.com/jpm/jpm-11-01325/article_deploy/html/images/jpm-11-01325-g003.png)
JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in
![The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpjpcrm.2015.50/MediaObjects/41533_2015_Article_BFnpjpcrm201550_Fig1_HTML.jpg)
The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine
![Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5c11ba10-3664-4bc8-8c7a-886a52cf0d3e/gr1.gif)
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine
![Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD - Respiratory Medicine Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2035580582/2051167636/gr1.jpg)
Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD - Respiratory Medicine
![Intraocular Pressure Quantitative Trait Locus disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials Intraocular Pressure Quantitative Trait Locus disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials](http://malacards.blob.core.windows.net/network-images-v5-6-8/intraocular_pressure_quantitative_trait_locus_related_diseases.jpg)
Intraocular Pressure Quantitative Trait Locus disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
![Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0c62734d-67ab-4f12-ba60-192e1b716d98/gr2.jpg)
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial - The Lancet Respiratory Medicine
![A current update on advanced drug delivery devices for nasal and pulmonary administration - ScienceDirect A current update on advanced drug delivery devices for nasal and pulmonary administration - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780128198384000031-f11-02-9780128198384.jpg)